Classify penicillins. Describe their mechanism of action, pharmacokinetics, uses and adverse effects.
Mechanism of Action
Penicillins share a beta-lactam ring, structurally resembling the terminal D-alanyl-D-alanine of the peptidoglycan precursor → They bind penicillin-binding proteins (PBPs) in the bacterial membrane → The key enzyme inhibited is transpeptidase, which cross-links peptidoglycan strands → The wall becomes mechanically weak → autolysins are also activated → The organism lyses under its own osmotic pressure — bactericidal, and only against actively dividing organisms
- Because they act only on dividing cells, penicillins are ineffective against dormant organisms and may be antagonised by a bacteriostatic drug given simultaneously
- The wall is absent in man, which is why penicillins have an enormous therapeutic index — the only serious hazard is allergy
Classification
| Group | Drugs | Spectrum and use |
|---|---|---|
| Natural penicillins | Benzylpenicillin (penicillin G, parenteral); phenoxymethylpenicillin (penicillin V, oral); procaine and benzathine penicillin (depot) | Streptococci, pneumococci, meningococci, Treponema, Clostridium, Actinomyces. Acid-labile and beta-lactamase sensitive. Benzathine penicillin every 3–4 weeks is the mainstay of rheumatic fever prophylaxis |
| Antistaphylococcal (beta-lactamase resistant) | Cloxacillin, flucloxacillin, methicillin, nafcillin | Penicillinase-producing staphylococcus aureus only; a bulky side chain protects the ring. Not active against MRSA |
| Aminopenicillins (extended spectrum) | Ampicillin, amoxicillin | Added gram-negative cover — E. Coli, Proteus, Haemophilus, Salmonella, Listeria, enterococci. Destroyed by beta-lactamase, hence the combination with clavulanic acid |
| Antipseudomonal | Piperacillin, ticarcillin, carbenicillin | Pseudomonas and other resistant gram-negatives; used with tazobactam |
| With beta-lactamase inhibitors | Amoxicillin + clavulanic acid; ampicillin + sulbactam; piperacillin + tazobactam | The inhibitor has little antibacterial activity of its own but binds and inactivates beta-lactamase — a "suicide" substrate protecting the penicillin |
| Reserve | Temocillin, mecillinam | Gram-negative infections |
CLINICAL PEARL
Clavulanic acid is a decoy, not an antibiotic. It has negligible antibacterial action of its own; it simply binds beta-lactamase irreversibly and is destroyed in the process, leaving the amoxicillin intact to reach its target. That is why the combination restores activity against organisms that had become resistant — and why it does nothing for resistance caused by an altered PBP, as in MRSA.
Pharmacokinetics
- Benzylpenicillin is acid-labile and must be given parenterally; phenoxymethylpenicillin and amoxicillin are acid-stable and orally active
- Amoxicillin is better absorbed than ampicillin and is less affected by food — the reason it largely replaced it
- Widely distributed; poor CSF penetration normally, but adequate when the meninges are inflamed — hence high-dose penicillin works in meningitis
- Excreted rapidly and unchanged by the kidney, largely by tubular secretion; probenecid blocks this and prolongs the level, an interaction once used deliberately when penicillin was scarce
- Short half-life of about 30 minutes, hence frequent dosing or depot preparations
- Dose reduction is needed in renal failure for high-dose regimens
Therapeutic Uses
- Streptococcal infections — pharyngitis, cellulitis, erysipelas, scarlet fever; Streptococcus pyogenes has never developed penicillin resistance, which is remarkable after eighty years of use
- Pneumococcal pneumonia and meningitis (where sensitive)
- Meningococcal disease — benzylpenicillin, including a pre-hospital dose
- Syphilis — benzathine penicillin remains the drug of choice at every stage, with no resistance recorded
- Rheumatic fever — treatment and long-term secondary prophylaxis with benzathine penicillin, which matters enormously in India
- Infective endocarditis — with an aminoglycoside for synergy
- Anthrax, diphtheria, tetanus, gas gangrene, actinomycosis, leptospirosis
- Amoxicillin — otitis media, sinusitis, urinary infection, typhoid, H. Pylori eradication, and endocarditis prophylaxis
Adverse Effects
- Hypersensitivity — the principal hazard, in 1 to 10%: rashes, urticaria, serum sickness, and anaphylaxis in about 0.05%, which is fatal in a proportion. Cross-reactivity exists across the whole class
- A history of "penicillin allergy" must be interrogated — most reported reactions are nausea or a non-specific rash, and wrongly labelling a patient denies them the safest and most effective antibiotic for life; skin testing and formal de-labelling are worthwhile
- The ampicillin rash in infectious mononucleosis — a maculopapular rash occurs in most patients given ampicillin during EBV infection; it is not a true allergy and does not preclude later penicillin use
- Gastrointestinal — diarrhoea, nausea; Clostridioides difficile colitis, particularly with co-amoxiclav
- Neurotoxicity — myoclonus and seizures with very high doses or in renal failure, especially if given intrathecally
- Jarisch–herxheimer reaction when treating syphilis
- Cholestatic hepatitis with co-amoxiclav; interstitial nephritis with methicillin
Resistance to Penicillins
| Mechanism | Explanation | Countermeasure |
|---|---|---|
| Beta-lactamase production | The commonest — the enzyme hydrolyses the beta-lactam ring. Staphylococcal penicillinase is plasmid-encoded and spread rapidly after penicillin was introduced | A beta-lactamase-stable penicillin (cloxacillin), or a beta-lactamase inhibitor (clavulanic acid) |
| Altered penicillin-binding protein | MRSA acquires mecA, producing PBP2a which has very low affinity for all beta-lactams; pneumococci acquire altered PBPs by transformation | Not overcome by inhibitors — a different class is needed (vancomycin, linezolid); or ceftaroline |
| Reduced penetration | Loss of outer membrane porins in gram-negatives | Agents with better penetration; carbapenems |
| Efflux | Active extrusion | Rarely overcome |
| Tolerance | The organism is inhibited but not killed — autolysins are defective | Combination with an aminoglycoside |
- The distinction matters clinically — beta-lactamase-mediated resistance is defeated by an inhibitor, whereas altered-target resistance is not, and requires an entirely different drug
Applied Aspects
- Benzathine penicillin every 3 to 4 weeks prevents recurrent rheumatic fever and progressive valve damage; adherence over years is the difficulty, and a register-based programme with reminders is what makes it work
- Penicillin remains first-line for streptococcal sore throat, and there is no reason to use a broader agent; treating it prevents rheumatic fever, which is still common in India
- Ask what the "penicillin allergy" actually was — nausea, diarrhoea and a family history are not allergies, and de-labelling restores access to the safest antibiotics
- Amoxicillin is preferred to ampicillin orally because absorption is better and less affected by food
- Co-amoxiclav is over-used — plain amoxicillin suffices for most community infections, and the clavulanate adds diarrhoea, cholestatic hepatitis and selection pressure
- Keep adrenaline immediately available wherever parenteral penicillin is given, and observe the patient for 20 to 30 minutes afterwards
- Warn about the Jarisch–Herxheimer reaction before treating syphilis or leptospirosis, so that the patient and staff do not mistake it for an allergic reaction and stop effective treatment
- Intrathecal penicillin must never be given — it causes convulsions and arachnoiditis; systemic high dose penetrates inflamed meninges adequately
- Amoxicillin remains first-line for otitis media, sinusitis and community-acquired pneumonia in most guidelines, and its low cost matters greatly in India
- Penicillin allergy labels are carried for life and rarely reviewed; formal assessment should be arranged for anyone likely to need beta-lactams repeatedly
All questions in Antimicrobials: General & Antibacterials
- Q1Describe the general principles of antimicrobial therapy including selective toxicity, classification, pharmacodynamic patterns and combination therapy. ★
- Q2Classify penicillins. Describe their mechanism of action, pharmacokinetics, uses and adverse effects. ★
- Q3Classify cephalosporins by generation. Describe the other beta-lactams and their uses and adverse effects. ★
- Q4Describe the aminoglycosides and macrolides with their mechanisms, uses and toxicity. ★
- Q5Describe the mechanisms of antimicrobial resistance, its spread and the principles of antimicrobial stewardship. ★
- SN1Describe the fluoroquinolones with their classification, uses and adverse effects. ★
- SN2Describe the tetracyclines and chloramphenicol with their uses and adverse effects. ★
- SN3Describe the sulphonamides and trimethoprim. Explain the basis of their synergy and the uses of co-trimoxazole. ★
- SN4Describe vancomycin and the other drugs used against MRSA and resistant gram-positive organisms. ★
- SN5Define chemoprophylaxis. Describe the principles of surgical and medical antimicrobial prophylaxis. ★
- SN6Define superinfection. Describe Clostridioides difficile colitis and its management. ★
- SN7Classify antiseptics and disinfectants. Describe the important agents and the factors affecting their activity.